Request Free Sample ×
ReportInfographic

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

UK Veterinary Equipment Disposables Market

ID: MRFR/MED/48988-HCR
200 Pages
Rahul Gotadki
Last Updated: April 06, 2026

UK Veterinary Equipment and Disposables Market Research Report: Size, Share, Trend Analysis By Types (Anesthesia Equipment, Critical Care Consumables, Temperature Management Equipment, Fluid Management Equipment, Patient Monitoring Equipment, Research Equipment, Rescue & Resuscitation Equipment, Others), By Animal Type (Small Animals, Large Animals) and By End-User (Veterinary Clinics, Veterinary Hospitals, Research Institutes, Others) - Growth Outlook & Industry Forecast 2025 To 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

UK Veterinary Equipment Disposables Market Infographic
Purchase Options
Compare License
Summary Table of Contents Segmentation Download PDF
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
  2.   1.1 EXECUTIVE SUMMARY
  3.     1.1.1 Market Overview
  4.     1.1.2 Key Findings
  5.     1.1.3 Market Segmentation
  6.     1.1.4 Competitive Landscape
  7.     1.1.5 Challenges and Opportunities
  8.     1.1.6 Future Outlook
  9. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
  10.   2.1 MARKET INTRODUCTION
  11.     2.1.1 Definition
  12.     2.1.2 Scope of the study
  13.       2.1.2.1 Research Objective
  14.       2.1.2.2 Assumption
  15.       2.1.2.3 Limitations
  16.   2.2 RESEARCH METHODOLOGY
  17.     2.2.1 Overview
  18.     2.2.2 Data Mining
  19.     2.2.3 Secondary Research
  20.     2.2.4 Primary Research
  21.       2.2.4.1 Primary Interviews and Information Gathering Process
  22.       2.2.4.2 Breakdown of Primary Respondents
  23.     2.2.5 Forecasting Model
  24.     2.2.6 Market Size Estimation
  25.       2.2.6.1 Bottom-Up Approach
  26.       2.2.6.2 Top-Down Approach
  27.     2.2.7 Data Triangulation
  28.     2.2.8 Validation
  29. 3 SECTION III: QUALITATIVE ANALYSIS
  30.   3.1 MARKET DYNAMICS
  31.     3.1.1 Overview
  32.     3.1.2 Drivers
  33.     3.1.3 Restraints
  34.     3.1.4 Opportunities
  35.   3.2 MARKET FACTOR ANALYSIS
  36.     3.2.1 Value chain Analysis
  37.     3.2.2 Porter's Five Forces Analysis
  38.       3.2.2.1 Bargaining Power of Suppliers
  39.       3.2.2.2 Bargaining Power of Buyers
  40.       3.2.2.3 Threat of New Entrants
  41.       3.2.2.4 Threat of Substitutes
  42.       3.2.2.5 Intensity of Rivalry
  43.     3.2.3 COVID-19 Impact Analysis
  44.       3.2.3.1 Market Impact Analysis
  45.       3.2.3.2 Regional Impact
  46.       3.2.3.3 Opportunity and Threat Analysis
  47. 4 SECTION IV: QUANTITATIVE ANALYSIS
  48.   4.1 Healthcare, BY Application (USD Million)
  49.     4.1.1 Surgical Equipment
  50.     4.1.2 Diagnostic Equipment
  51.     4.1.3 Monitoring Equipment
  52.     4.1.4 Anesthesia Equipment
  53.     4.1.5 Therapeutic Equipment
  54.   4.2 Healthcare, BY End Use (USD Million)
  55.     4.2.1 Veterinary Clinics
  56.     4.2.2 Animal Hospitals
  57.     4.2.3 Research Laboratories
  58.     4.2.4 Pet Care Centers
  59.   4.3 Healthcare, BY Product Type (USD Million)
  60.     4.3.1 Surgical Instruments
  61.     4.3.2 Diagnostic Devices
  62.     4.3.3 Anesthesia Machines
  63.     4.3.4 Consumables
  64.     4.3.5 Monitoring Systems
  65.   4.4 Healthcare, BY Animal Type (USD Million)
  66.     4.4.1 Companion Animals
  67.     4.4.2 Livestock
  68.     4.4.3 Equine
  69.     4.4.4 Exotic Animals
  70.   4.5 Healthcare, BY Distribution Channel (USD Million)
  71.     4.5.1 Online Sales
  72.     4.5.2 Veterinary Distributors
  73.     4.5.3 Direct Sales
  74.     4.5.4 Retail Pharmacies
  75. 5 SECTION V: COMPETITIVE ANALYSIS
  76.   5.1 Competitive Landscape
  77.     5.1.1 Overview
  78.     5.1.2 Competitive Analysis
  79.     5.1.3 Market share Analysis
  80.     5.1.4 Major Growth Strategy in the Healthcare
  81.     5.1.5 Competitive Benchmarking
  82.     5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
  83.     5.1.7 Key developments and growth strategies
  84.       5.1.7.1 New Product Launch/Service Deployment
  85.       5.1.7.2 Merger & Acquisitions
  86.       5.1.7.3 Joint Ventures
  87.     5.1.8 Major Players Financial Matrix
  88.       5.1.8.1 Sales and Operating Income
  89.       5.1.8.2 Major Players R&D Expenditure. 2023
  90.   5.2 Company Profiles
  91.     5.2.1 Vetronic Services Ltd (GB)
  92.       5.2.1.1 Financial Overview
  93.       5.2.1.2 Products Offered
  94.       5.2.1.3 Key Developments
  95.       5.2.1.4 SWOT Analysis
  96.       5.2.1.5 Key Strategies
  97.     5.2.2 Henry Schein Animal Health (GB)
  98.       5.2.2.1 Financial Overview
  99.       5.2.2.2 Products Offered
  100.       5.2.2.3 Key Developments
  101.       5.2.2.4 SWOT Analysis
  102.       5.2.2.5 Key Strategies
  103.     5.2.3 Boehringer Ingelheim Vetmedica GmbH (DE)
  104.       5.2.3.1 Financial Overview
  105.       5.2.3.2 Products Offered
  106.       5.2.3.3 Key Developments
  107.       5.2.3.4 SWOT Analysis
  108.       5.2.3.5 Key Strategies
  109.     5.2.4 Zoetis Inc (US)
  110.       5.2.4.1 Financial Overview
  111.       5.2.4.2 Products Offered
  112.       5.2.4.3 Key Developments
  113.       5.2.4.4 SWOT Analysis
  114.       5.2.4.5 Key Strategies
  115.     5.2.5 Elanco Animal Health (US)
  116.       5.2.5.1 Financial Overview
  117.       5.2.5.2 Products Offered
  118.       5.2.5.3 Key Developments
  119.       5.2.5.4 SWOT Analysis
  120.       5.2.5.5 Key Strategies
  121.     5.2.6 Vetoquinol SA (FR)
  122.       5.2.6.1 Financial Overview
  123.       5.2.6.2 Products Offered
  124.       5.2.6.3 Key Developments
  125.       5.2.6.4 SWOT Analysis
  126.       5.2.6.5 Key Strategies
  127.     5.2.7 MSD Animal Health (US)
  128.       5.2.7.1 Financial Overview
  129.       5.2.7.2 Products Offered
  130.       5.2.7.3 Key Developments
  131.       5.2.7.4 SWOT Analysis
  132.       5.2.7.5 Key Strategies
  133.     5.2.8 Virbac (FR)
  134.       5.2.8.1 Financial Overview
  135.       5.2.8.2 Products Offered
  136.       5.2.8.3 Key Developments
  137.       5.2.8.4 SWOT Analysis
  138.       5.2.8.5 Key Strategies
  139.   5.3 Appendix
  140.     5.3.1 References
  141.     5.3.2 Related Reports
  142. 6 LIST OF FIGURES
  143.   6.1 MARKET SYNOPSIS
  144.   6.2 UK MARKET ANALYSIS BY APPLICATION
  145.   6.3 UK MARKET ANALYSIS BY END USE
  146.   6.4 UK MARKET ANALYSIS BY PRODUCT TYPE
  147.   6.5 UK MARKET ANALYSIS BY ANIMAL TYPE
  148.   6.6 UK MARKET ANALYSIS BY DISTRIBUTION CHANNEL
  149.   6.7 KEY BUYING CRITERIA OF HEALTHCARE
  150.   6.8 RESEARCH PROCESS OF MRFR
  151.   6.9 DRO ANALYSIS OF HEALTHCARE
  152.   6.10 DRIVERS IMPACT ANALYSIS: HEALTHCARE
  153.   6.11 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
  154.   6.12 SUPPLY / VALUE CHAIN: HEALTHCARE
  155.   6.13 HEALTHCARE, BY APPLICATION, 2024 (% SHARE)
  156.   6.14 HEALTHCARE, BY APPLICATION, 2024 TO 2035 (USD Million)
  157.   6.15 HEALTHCARE, BY END USE, 2024 (% SHARE)
  158.   6.16 HEALTHCARE, BY END USE, 2024 TO 2035 (USD Million)
  159.   6.17 HEALTHCARE, BY PRODUCT TYPE, 2024 (% SHARE)
  160.   6.18 HEALTHCARE, BY PRODUCT TYPE, 2024 TO 2035 (USD Million)
  161.   6.19 HEALTHCARE, BY ANIMAL TYPE, 2024 (% SHARE)
  162.   6.20 HEALTHCARE, BY ANIMAL TYPE, 2024 TO 2035 (USD Million)
  163.   6.21 HEALTHCARE, BY DISTRIBUTION CHANNEL, 2024 (% SHARE)
  164.   6.22 HEALTHCARE, BY DISTRIBUTION CHANNEL, 2024 TO 2035 (USD Million)
  165.   6.23 BENCHMARKING OF MAJOR COMPETITORS
  166. 7 LIST OF TABLES
  167.   7.1 LIST OF ASSUMPTIONS
  168.     7.1.1
  169.   7.2 UK MARKET SIZE ESTIMATES; FORECAST
  170.     7.2.1 BY APPLICATION, 2026-2035 (USD Million)
  171.     7.2.2 BY END USE, 2026-2035 (USD Million)
  172.     7.2.3 BY PRODUCT TYPE, 2026-2035 (USD Million)
  173.     7.2.4 BY ANIMAL TYPE, 2026-2035 (USD Million)
  174.     7.2.5 BY DISTRIBUTION CHANNEL, 2026-2035 (USD Million)
  175.   7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  176.     7.3.1
  177.   7.4 ACQUISITION/PARTNERSHIP
  178.     7.4.1

UK Healthcare Market Segmentation

Healthcare By Application (USD Million, 2026-2035)

  • Surgical Equipment
  • Diagnostic Equipment
  • Monitoring Equipment
  • Anesthesia Equipment
  • Therapeutic Equipment

Healthcare By End Use (USD Million, 2026-2035)

  • Veterinary Clinics
  • Animal Hospitals
  • Research Laboratories
  • Pet Care Centers

Healthcare By Product Type (USD Million, 2026-2035)

  • Surgical Instruments
  • Diagnostic Devices
  • Anesthesia Machines
  • Consumables
  • Monitoring Systems

Healthcare By Animal Type (USD Million, 2026-2035)

  • Companion Animals
  • Livestock
  • Equine
  • Exotic Animals

Healthcare By Distribution Channel (USD Million, 2026-2035)

  • Online Sales
  • Veterinary Distributors
  • Direct Sales
  • Retail Pharmacies

Related Reports

No regional reports available for this market.

No country-specific reports available for this market.

Customer Stories
Case Study Cover Image
Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization ✓ ✓ ✓
Direct Access to Analyst ✓ ✓ ✓
Deliverable Format ✓ ✓ ✓
Platform Access ✗ ✗ ✓
Discount on Next Purchase 10% 15% 15%
Printable Versions ✗ ✗ ✓